According to the Washington Post, what started as an antitrust lawsuit brought by states over just two drugs in 2016 has exploded into an investigation of alleged price-fixing involving at least 16 companies and 300 drugs.
1. What was the “shorthand” between executives used for? Give an example.
2. According to the article, who are the victims of these price-fixing schemes?
3. Who are some of the companies that banded together for price-fixing and what are some of the extraordinary percentage markups charged?
4. What did you find the most interesting about this article?
Rowland, C. (2018). Investigation of generic ‘cartel’ expands to 300 drugs. Washington Post, Dec. 9 (Retrievable online at https://www.washingtonpost.com/business/economy/investigation-of-generic-cartel-expands-to-300-drugs/2018/12/09/fb900e80-f708-11e8-863c-9e2f864d47e7_story.html)